Skip to main navigation Skip to search Skip to main content

The ultimate radiochemical nightmare: upon radio-iodination of Botulinum neurotoxin A, the introduced iodine atom itself seems to be fatal for the bioactivity of this macromolecule

  • Janneke I. M. van Uhm*
  • , Gerard W. M. Visser
  • , Marcel J. van der Schans
  • , Albert A. Geldof
  • , Eric J. H. Meuleman
  • , Jakko A. Nieuwenhuijzen
  • *Corresponding author for this work
  • Amsterdam UMC - Vrije Universiteit Amsterdam
  • Netherlands Organisation for Applied Scientific Research

Research output: Contribution to journalArticleAcademicpeer-review

3 Downloads (Pure)

Abstract

Background: Botulinum neurotoxin A (BoNT-A) is a highly neurotoxic drug and frequently used in patients. Knowledge on the optimal way of administration of BoNT-A and its subsequent distribution is still rather limited. An accurate method for monitoring these processes might be the use of radiolabelled BoNT-A. In this paper, we report our feasibility study on labelling BoNT-A with high-dose iodine-125 (125I) via IODOGEN-coated BoNT-A method.
Original languageEnglish
Article number5
JournalEJNMMI research
Volume5
Issue number1
DOIs
Publication statusPublished - 2015

Fingerprint

Dive into the research topics of 'The ultimate radiochemical nightmare: upon radio-iodination of Botulinum neurotoxin A, the introduced iodine atom itself seems to be fatal for the bioactivity of this macromolecule'. Together they form a unique fingerprint.

Cite this